Search

A closer look at the new wave of glaucoma surgery – radical or old school?

Glaucoma is a challenging condition to treat because the exact pathophysiology remains unclear and the only readily modifiable factor is the intraocular pressure (IOP). Additionally, most glaucoma patients are completely asymptomatic, yet are often subjected to lifelong medical therapy. The...

Burning vision: vision loss from misuse of ‘toy’ laser pens in children

A case series of five children with macular burns due to the misuse of novelty laser products, purchased online or abroad, was undertaken at the Royal Hallamshire Hospital and The Children’s Hospital, Sheffield [1]. All patients were from the Sheffield...

Can e-learning help bridge the ophthalmology teaching gap?

The authors ask whether e-learning can help to address the current lack of ophthalmology teaching in the undergraduate curriculum. Studies among the United Kingdom, Australasian, Canadian and Asian medical schools have found that students on average spent just over a...

Ambitions for sustainable service recovery amidst an escalating post-COVID backlog

Rod McNeil reviews plans, activity and solutions to better address the post-COVID backlog and bolster sustainable service recovery. Ophthalmology was the busiest outpatient specialty during the three years to March 2020 across the English NHS and again recorded the highest...

My Top Five: Duke Elder Undergraduate Ophthalmology Prize Exam Tips

The prestigious Duke Elder Undergraduate Ophthalmology exam in the UK is aimed at medical students who have completed their ophthalmology undergraduate teaching but is open to all medical undergraduates provided they have not graduated at the time of the examination....

Passing the Refraction Certificate as a Foundation doctor

Application for ophthalmic specialist training (OST) is competitive. This means you should consider making every effort to maximise your portfolio points, as it may have a significant contribution to your OST application ranking. The “Commitment to Specialty” section is the...

Emerging therapies for geographic atrophy: complement inhibitors show potential to slow progression and preserve RPE and photoreceptor integrity

Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) characterised by progressive, irreversible loss of the retinal pigment epithelium (RPE) and photoreceptors and is estimated to account for approximately 10% of AMD-related blindness [1-4]. The Age-Related Eye...

Update on emerging therapies for age-related macular degeneration

The 23rd European Society of Retina Specialists (EURETINA) Congress, held in Amsterdam, the Netherlands, provided a timely update on anti-complement therapy for geographic atrophy and emerging investigational therapies for neovascular age-related macular degeneration. Anti-complement therapy for geographic atrophy Geographic atrophy...

The All Eyes Foundation

At its core, All Eyes Foundation (AEF) wishes to help bring vision back to Iraq, and it intends to do this through ophthalmic subspecialty training, mentoring and infrastructure development. Based in Najaf, just over 100 miles south of Baghdad, the...

In conversation with Robert MacLaren

Professor Robert MacLaren gave the Keeler Lecture at the Royal College of Ophthalmologists Annual Meeting in May 2019 on gene therapy for retinitis pigmentosa. We caught up with him afterwards to find out more. What are the key messages of...

In conversation with Imran Rahman (CHEC)

Imran Rahman, CEO and Consultant Ophthalmologist, CHEC, spoke to Chris Henson about tackling the COVID-19 backlog, community-based support for the NHS, and the digitisation of healthcare. Without major intervention, will we ever see an end to the COVID-19-induced NHS backlog,...